Lina Polimeni, chief corporate brand officer at Lilly, notes that public perception of the company has historically been ...

Amphastar's Q2 2024 revenue grew 25% YOY to $182.4 million, primarily driven by BAQSIMI and Primatene MIST sales. Find out ...

A turbulent series of events around the supply of Eli Lilly’s blockbuster weight loss treatment has raised concerns around ...

A new bombshell has been dropped in the scandal-plagued world of Alzheimer’s disease drug development. | Between the two ...

A mong the many newcomers to the business of weight-loss drugs is Hims & Hers, an American e-pharmacy better known for ...

First the drugs tackled diabetes. Then, with just an injection a week, they took on obesity. Now they are being found to ...

Under US law, compounding pharmacies can make and sell patent-protected drugs that are on the FDA's shortages list in limited ...

Calling the decision not to disclose the genetic results “certainly troubling” and “ethically fraught,” George Perry, editor ...

The Danish drugmaker Novo Nordisk argues that semaglutide, the active ingredient in Ozempic and Wegovy, are too complex for ...

Currently, financial markets are experiencing a mix of optimism and caution as investors react to changing economic ...

And it looks like Johnson & Johnson (NYSE: JNJ) just hit a bump in the road that'll pave the way for Eli Lilly (NYSE: LLY) to ...

Currently, financial markets are experiencing a mix of optimism and caution as investors react to changing economic ...